220 related articles for article (PubMed ID: 2547666)
1. Metastatic vipoma arising from colonic primary tumour.
Bradley C; Haddock G; Pickard RG; Rankin EM
Eur J Surg Oncol; 1989 Aug; 15(4):386-9. PubMed ID: 2547666
[TBL] [Abstract][Full Text] [Related]
2. [Long-term therapy of a metastasizing pancreatic vipoma using the somatostatin derivative octreotide].
Flückiger A; Schlup P
Schweiz Med Wochenschr; 1992 Aug; 122(33):1221-3. PubMed ID: 1326786
[TBL] [Abstract][Full Text] [Related]
3. VIPoma syndrome: challenges in management.
Adam N; Lim SS; Ananda V; Chan SP
Singapore Med J; 2010 Jul; 51(7):e129-32. PubMed ID: 20730389
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis of Verner-Morrison syndrome (VDHA) and its treatment with sandostatin an streptozocitin].
Várkonyi TT; Velösy B; Nagy I; Németh J; Lonovics J
Orv Hetil; 1993 Nov; 134(47):2599-602. PubMed ID: 8247522
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion.
Williams G; Anderson JV; Williams SJ; Bloom SR
Acta Endocrinol Suppl (Copenh); 1987; 286():26-36. PubMed ID: 2892335
[TBL] [Abstract][Full Text] [Related]
6. [W.D.H.A. Syndrome due to occult neuroendocrine malignancy with concomitant liver metastases].
Rammer M; Kirchgatterer A; Höbling W; Stockhammer M; Knoflach P
Z Gastroenterol; 2003 Feb; 41(2):185-9. PubMed ID: 12592602
[TBL] [Abstract][Full Text] [Related]
7. Metastatic pancreatic VIPoma: deteriorating clinical course and successful treatment by liver transplantation.
Hengst K; Nashan B; Avenhaus W; Ullerich H; Schlitt HJ; Flemming P; Pichlmayr R; Domschke W
Z Gastroenterol; 1998 Mar; 36(3):239-45. PubMed ID: 9577908
[TBL] [Abstract][Full Text] [Related]
8. Treatment of metastatic Vipoma by liver transplantation.
Bramley PN; Lodge JP; Losowsky MS; Giles GR
Clin Transplant; 1990 Oct; 4(5 part 1):276-8; discussion 279. PubMed ID: 10150088
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases.
Kraenzlin ME; Ch'ng JL; Wood SM; Carr DH; Bloom SR
Gastroenterology; 1985 Jan; 88(1 Pt 1):185-7. PubMed ID: 2856877
[TBL] [Abstract][Full Text] [Related]
10. Primary hepatic vipoma.
Ayub A; Zafar M; Abdulkareem A; Ali MA; Lingawi T; Harbi A
Am J Gastroenterol; 1993 Jun; 88(6):958-61. PubMed ID: 8389095
[TBL] [Abstract][Full Text] [Related]
11. Sporadic pancreatic vasoactive intestinal peptide-producing tumor (VIPoma) in a 47-year-old male.
Abu-Zaid A; Azzam A; Abudan Z; Algouhi A; Almana H; Amin T
Hematol Oncol Stem Cell Ther; 2014 Sep; 7(3):109-15. PubMed ID: 24785507
[TBL] [Abstract][Full Text] [Related]
12. [Verner-Morrison syndrome revealing a ganglioneuroblastoma in an adult].
Neuzillet C; Hammel P; Baudin E; Couvelard A; Elias D; Casiraghi O; Cazals-Hatem D; Pelletier AL; Lévy P; Ruszniewski P
Gastroenterol Clin Biol; 2008 Mar; 32(3):282-8. PubMed ID: 18403149
[TBL] [Abstract][Full Text] [Related]
13. Metastatic pancreatic vipoma: a case report of clinical response following treatment with corticosteroids and actinomycin D.
Fennelly JJ; Cantwell B; Fielding JF; FitzGerald O; Collins PG; Buchanan KD
Clin Oncol; 1982 Jun; 8(2):167-70. PubMed ID: 6286202
[No Abstract] [Full Text] [Related]
14. A case of vasoactive intestinal polypeptideoma.
Sycamnias J; Strahl B; Stride P; Chern B; Paranavithana L
N Z Med J; 2009 Jun; 122(1296):64-8. PubMed ID: 19652683
[No Abstract] [Full Text] [Related]
15. Vasoactive intestinal peptide (VIP) secreting tumour of the pancreas.
Sandström R; Alhava EM; Poikolainen E; Puittinen J; Soimakallio S
Ann Chir Gynaecol; 1981; 70(3):124-7. PubMed ID: 6275768
[TBL] [Abstract][Full Text] [Related]
16. [Transcatheter embolization of metastatic liver VIPoma: report of a case].
Ito S; Kasturagi M; Otsuji H; Ohishi H; Uchida H; Nakano H; Yabuta M; Ishikawa H
Rinsho Hoshasen; 1987 Oct; 32(10):1169-72. PubMed ID: 2832643
[No Abstract] [Full Text] [Related]
17. In vitro release of vasoactive intestinal polypeptide and pancreatic polypeptide from human VIPoma cells and its inhibition by somatostatin analogue (SMS 201-995).
Yasunami Y; Funakoshi A; Ryu S; Shinozaki H; Jimi A; Miyazaki K; Ikeda S
Surgery; 1994 Jun; 115(6):713-7. PubMed ID: 8197564
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic islet cell tumor producing vasoactive intestinal polypeptide and calcitonin.
Eskens FA; Roelofs EJ; Hermus AR; Verhagen CA
Anticancer Res; 1997; 17(6D):4667-70. PubMed ID: 9494586
[TBL] [Abstract][Full Text] [Related]
19. Vipoma of the pancreas complicating ulcerative colitis.
Yanagi H; Kusunoki M; Sakanoue Y; Shoji Y; Yamamura T; Murai M; Kikkawa N; Utsunomiya J
Am J Gastroenterol; 1991 Aug; 86(8):1066-9. PubMed ID: 1650130
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and treatment of pancreatic islet cell tumors producing vasoactive intestinal polypeptide (VIPoma)].
Kábrt J; Dvorák M; Skrha J; Sindelka G
Vnitr Lek; 1999 Oct; 45(10):606-9. PubMed ID: 10951870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
